Saturday, July 17, 2010 10:36:19 AM
Bovine Mastitis and Milking Management
What is interesting is that for every clinical case of mastitis, there will be 15 to 40 sub-clinical cases. This is the market ICCC is targeting with Mast Out.
Clinical Mastitis -- visible signs of mastitis which include:
Mild signs flakes or clots in the milk, may have slight swelling of infected quarter.
Severe signs secretion abnormal, hot, swollen quarter or udder; cow may have a fever, rapid pulse, loss of appetite, dehydration and depression; death may occur.
Subclinical Mastitis -- no visible signs of the disease:
Somatic cell count (SCC) of the milk will be elevated.
Bacteriological culturing of milk will detect bacteria in the milk.
Causes the greatest financial loss to dairy farmers through lowered milk production.
For every clinical case of mastitis, there will be 15 to 40 sub-clinical cases.
Somatic Cell Count (SCC) -- the number of leukocytes or white blood cells per milliliter of milk.
Normal milk will have less than 200,000 cells per milliliter.
An elevated SCC is an indication of inflammation in the udder.
Bulk tank SCC gives an indication of the level of sub-clinical mastitis and the loss of milk production in a herd due to mastitis.
http://www.ag.ndsu.edu/pubs/ansci/dairy/as1129w.htm
Recent ICCC News
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 • GlobeNewswire Inc. • 04/09/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 06:55:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:32 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 • GlobeNewswire Inc. • 02/16/2024 02:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:05:32 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023 • GlobeNewswire Inc. • 01/08/2024 09:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 08:22:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:05:46 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/07/2023 05:15:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 08:05:21 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 • GlobeNewswire Inc. • 10/05/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 04:25:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2023 06:49:33 PM
- ImmuCell Announces Submission of CMC Technical Section to the FDA • GlobeNewswire Inc. • 08/29/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:44 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 • GlobeNewswire Inc. • 08/10/2023 08:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 • GlobeNewswire Inc. • 08/07/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 01:04:28 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/13/2023 06:28:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 08:05:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM